Dimensional Fund Advisors’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Dimensional Fund Advisors's SGMT Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Sagimet Biosciences (SGMT) stake by 33% in Q3 2026, buying an estimated $1.19M and bringing the position to 527,478 shares worth $5.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.
Dimensional Fund Advisors first reported a position in SGMT in Q4 2024 and has held it in 8 quarters since. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Dimensional Fund Advisors held 527,478 shares of Sagimet Biosciences worth $5.21M as of Q3 2026.
- Dimensional Fund Advisors bought 129,506 Sagimet Biosciences shares in Q3 2026, an estimated $1.19M.
- Sagimet Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2490 holding.
- Dimensional Fund Advisors first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 8 quarters since.
- 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.